Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients

Pediatric Transplantation

Volumn 10, Issue 1, 2006, Pages 67-73

  Shishido, Seiichirou ^a   Sato, Hiroyuki ^a   Asanuma, Hiroshi ^a   Shindo, Masahito ^a   Hataya, Hiroshi ^a   Ishikura, Kenji ^a   Hamasaki, Yuko ^a   Goto, Miwa ^a   Ikeda, Masahiro ^a   Honda, Masataka ^b  

^a TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^b Tokyo Metropolitan Hachioji Children's Hospital   (Japan)

Author keywords

Children; Kidney transplantation; Oral glucose tolerance tests; Post transplant diabetes mellitus

Indexed keywords

CYCLOSPORIN A; HEMOGLOBIN A1C; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; ORAL GLUCOSE TOLERANCE TEST; PEDIATRICS; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33645998421     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00459.x     Document Type: Article

References (30)

1. M arkell M. Clinical impact of posttransplant diabetes mellitus Transplant Proc 2001 33 Suppl. 5A 19S 22S
2. J indal R H jelmesaeth J. Impact and management of posttransplant diabetes mellitus Transplantation 2000 70 Suppl. 11 SS58 63
3. K asiske BL G uijarro C M assy ZA W iederkehr MR M A JZ. Cardiovascular disease after renal transplantation J Am Soc Nephrol 1996 7 158 165
4. K asiske BL S nyder JJ G ilbertson D M atas AJ. Diabetes mellitus after kidney transplantation in the United States Am J Tranplant 2003 3 178 185
5. A l -U zri A. S tablein D C ohn R. Posttransplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Transplantation 2001 72 1020 1024
6. T rompeter R F iller G W ebb NJ et al. Randomized trial of tacrolimus versus cyclospolin microemulsion in renal transplantation Pediatr Nephrol 2002 17 141 149
7. G reenspan LC G itelman SE L eung MA G lidden DV M athias RS. Increased incidence in post-transplant diabetes mellitus in children: A case-control analysis Pediatr Nephrol 2002 17 1 5
8. F irst MR G erber DA H ariharan S K aufman DB S hapiro R. Posttransplant diabetes mellitus in kidney allograft recipients: Incidence, risk factors, and management Transplantation 2002 73 379 386
9. R osenbloom AL J oe JR Y oung RS W inter WE. Emerging epidemic of type 2 diabetes in youth Diabetes Care 1999 22 345 354
10. P inhas -H amiel O D olan LM D aniels SR S tandiford D K houry PR Z eitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents J Pediatr 1996 128 605 615
11. American Diabetes Association Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 2003 26 Suppl. 1 5
12. M atsumoto K M iyake S Y ano M et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects Diabetes Care 1997 20 1562 1568
13. T okumura M N anri S K imura K T anaka T F ujita H. Height-specific body mass index reference curve for Japanese children and adolescents 5-17 years of age Pediatr Int 2004 45 525 530
14. S aenger P. Metabolic consequence of growth hormone treatment in pediatric practice Horm Res 2000 53 Suppl. 1 60 69
15. F iller G A mendt P K ohnert KD D evaux S E hrich JH. Glucose tolerance and insulin secretion in children before and during recombinant growth hormone treatment Horm Res 1998 50 32 37
16. M ak RH. Carbohydrate metabolism in uremia Pediatr Nephrol 1989 3 201 208 review
17. M ak RH. Insulin branch-chain amino acids, and growth failure in uremia Pediatr Nophrol 1998 12 637 642
18. D efronzo RA A lvestrand A S mith D H endler R. Insulin resistance in uremia J Clin Invest 1981 67 19
19. P anarello G C alianno G D e B az H S ignori D C appelletti P T esio F. Does continuous ambulatory peritoneal dialysis induce hypercholesterolemia Perit Dial Int 1993 13 Suppl. 2 S421 S423
20. H jelmesaeth J H artmann A K ofstad J E geland T S tenstrom J F auchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: The effect on glucose tolerance Nephrol Dial Transplant 2001 16 829 835
21. W eir MR F ink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications Am J Kidney Dis 1999 34 1 13
22. M arkell M. Post-transplant diabetes: Incidence, relationship to choice of immunosuppressive drugs, and treatment protocol Adv Ren Replace Ther 2001 8 64 69
23. P olastri L G albiati F B ertuzzi F et al. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells Acta Diabetol 2002 39 229 233
24. F iller G N euschulz I V ollmer I A mendt P H ocher B. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients Nephrol Dial Transplant 2000 15 867 871
25. V an D uijnhoven EM B oots JMM C hristiaans MHL W olffenbuttel BHR van H ooff JP. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study J Am Soc Nephrol 2001 12 583 588
26. L auritzen JB L auritsen M O lsen E T immerman I. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients Metabolism 1982 31 1096 1099
27. A mendt P F iller G. Glucose metabolism in children with renal failure: Oral or intervenous glucose tolerance Exp Clin Endocrinol Diabetes 2000 108 253 258
28. S haw JE H odge AM D e C ourten M C hitson P Z immet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality Diabetologia 1999 42 1050 1054
29. N eu AM H o PL F ine RN F urth SL F ivush BA. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study Pediatr Transplant 2003 7 217 222
30. W oodward RS S chnitzler MA B aty J et al. Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients Am J Transplant 2003 3 512 513